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Functional Results and Subjective Benefit of a
Transcutaneous Bone Conduction Device in Patients
With Single-Sided Deafness
Roman D. Laske, Christof Ro¨o¨sli, Flurin Pfiffner, Dorothe Veraguth,
and Alex M. Huber
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Zurich,
Zurich, Switzerland
Objective: To analyze speech discrimination scores and subjec-
tive benefit of a transcutaneous bone conduction device (tBCD)
in adults with single-sided deafness (SSD).
Study Design: Prospective cohort study.
Setting: Tertiary referral center.
Patients: Nine adults with SSD for more than 1 year and normal
hearing on the contralateral side (PTAG30 dBHL)were implanted
with a tBCD.
Interventions: Transmastoidal implantation of a Bonebridge
(BB, MED-EL) tBCD.
Main Outcome Measures: Aided and unaided speech discrim-
ination scores in three different spatial settings were measured
using the Oldenburg sentence test (OLSA). Quality of life was
assessed by two questionnaires, the Bern Benefit in Single Sided
Deafness Questionnaire (BBSS) and the Speech, Spatial and
Qualities of Hearing scale for benefit questionnaire (SSQ-B).
Results: Speech discrimination scores measured by OLSA
showed a mean signal-to-noise ratio improvement of 1.7 dB
SPL for the aided condition compared with the unaided con-
dition in the setting where the sound signal is presented on the
side of the implanted ear and the noise is coming from the front
(p G 0.05). In the other two settings (signal and noise from front;
signal from normal hearing ear and noise from front), the signal-
to-noise ratio did not change significantly. This benefit be-
came manifest after 6 months. Good satisfaction was indicated
by positive results on the questionnaires.
Conclusion: Speech discrimination in noise for patients im-
planted with the BB is comparable with patients with other
bone conduction hearing aids. A learning curve is clearly
detectable. The subjective benefit was rated positively by the
patients. With the advantage of intact skin conditions after
implantation, the BB is an adequate option for patients with SSD.
Key Words: Single-sided deafnessVBone conductionVBone
conduction hearing aidVSpeechVDiscrimination.
Otol Neurotol 36:1151Y1156, 2015.
Single-sided sensorineural hearing loss or single-sided
deafness (SSD) results in a decline in speech recognition
in noise because of the head shadow effect (1,2), and a
decrease in sound localization. Most patients affected by
SSD report a hearing handicap (3). Although some pa-
tients cope well with SSD and prefer no treatment, others
are highly disturbed and want treatment.
There is a growing number of different auditory reha-
bilitation options available today (4): 1) Contralateral
routing of signal (CROS) hearing aid systems are a
noninvasive option, where sound is transmitted from the
deaf ear to the better ear by wireless technology. The
main drawback is that the better ear must also be fit with
a device in addition to the deaf ear, where the microphone
is located (5,6); 2) Bone-anchored hearing aid systems
transmit sound to the better side by bone conduction
(BC). This technique was introduced in 1977 (7) and
was originally used for conductive and mixed hearing
losses before the indication was expanded for use with
SSD, and Food and Drug Administration approval was
acquired in 2002 (8). Several studies have shown signifi-
cant speech understanding improvement and improve-
ment of quality of life for SSD (9Y13); 3) Nonsurgical
removable BC prosthetic hearing devices transmit sound
via the teeth (14); 4) The cochlear implant is an inva-
sive option with the goal of restoring true binaural hear-
ing. This option is being offered to a growing number of
patients with SSD (15,16).
The Bonebridge (BB, MED-EL) transcutaneous BC
device (tBCD) was introduced in 2012 (17Y19). The
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system consists of a BC implant with a floating mass trans-
ducer, an electrical demodulator, and a receiver coil that is
fully implanted, leaving intact skin conditions after wound
healing. The sound processor including microphones and
battery is worn externally. In an experimental cadaver study
(17), noninferiority of the BB in comparison with a percu-
taneous BC device (pBCD), the BAHA (Cochlear Bone
Anchored Solutions AG, Mo¨lnlycke, Sweden), was shown
for both, the stimulation of the same-sided cochlea as well as
the opposite cochlea for promontory vibration. Clinically,
tBCDs have been used primarily for resolution of conduc-
tive and mixed hearing loss (20).
To our knowledge, no reports on tBCD for use with
SSD patients have been published. The aim of this study
was to analyze functional and subjective benefit after
implantation of a tBCD in patients with SSD.
PATIENTS AND METHODS
Subjects
This study was designed as a prospective cohort study in-
cluding nine adult patients with SSD undergoing implantation of a
tBCD (BB,MED-EL) between October 2012 and September 2013.
All implantations were performed in one tertiary referral center.
The study protocol was approved by the local ethic committee
(Study Code 2012BB003, Ref. KEK-ZH-Nr:2012-0240), and the
study was carried out according to the declaration of Helsinki (21).
Audiologic SSD inclusion criteria were defined as nonmea-
sureable BC thresholds for the frequencies of 500, 1,000, 2,000, and
3,000 Hz or as a maximal speech discrimination score of 50% at a
presentation level of 100 dBSPL, or less on the side of the affected
ear, measured with appropriate masking in the contralateral ear
and under headphones. In addition, the air conduction (AC) pure
tone average (PTA, 500, 1,000, 2,000, and 3,000 Hz) had to be
30 dB HL or less on the unaffected side.
Patients fulfilling these inclusion criteria were counseled about
four rehabilitation options: 1) no intervention, 2) use of a CROS
hearing aid, 3) pBCD implantation, and 4) BB implantation. All
included subjects tested a CROS hearing aid and a BC device
mounted on a headband for several weeks in everyday situations
prior to their final decision. Patients were not counseled about a
cochlear implant because this option for SSD is not covered by
medical insurance in the country where the study was conducted.
The tBCD was implanted as described by Manrique et al. (22)
under general anesthesia. An L-shaped retroauricular skin incision
was used, and a counter-rotating muscle-periost flap was elevated.
The skin thickness was measured and subcutaneous tissue was
removed if necessary. Next, a notch of the size of the tBCD (16mm
diameter, 9 mmdepth) was drilled into the mastoid, and the device
was fixed with two screws. The muscle-periost flap was adapted
and the skin closed allowing a two-layer closure of the flap.
The first fitting took place approximately 4 to 5 weeks after
implantation. Target curves were calculated from the BC of the un-
affected ear using the SYMFIT 6.1 (MED-EL, Austria) andConnexx
V6.5 (Siemens, Germany) software. The second fitting appoint-
ment was scheduled 6months later, and patients were instructed to
call for an earlier appointment if necessary.
Audiometry
Pre- and postoperative pure tone audiometry for each side at
500, 1,000, 2,000, 3,000, and 4,000 Hz was conducted in accor-
dancewith ISO 8253-1 and 8253-3. Frequencies with no responses
at the maximum level of the audiometer were entered as maximum
output plus 5 dB. Preoperative maximal speech understanding was
determined using the Swiss version of the German Freiburger test
(monosyllables) (23). Speech perception in noise was measured
using a closed-set sentence test, the Oldenburg Sentence Test
(OLSA) (24). The OLSA-noise (pseudo continuous) served as the
noise source and was located in the frontal position (N0) in all
spatial settings. One long sentence list was used to measure each
situation. The sound signal was presented from three different
positions resulting in three test setups (S0N0, SCLN0, SBBN0), as
shown in Figure 2b. The noise level was set at 65 dB SPL, and the
speech level changed adaptively according to the number of
words repeated correctly (25). Results were measured as a signal-
to-noise ratio (SNR) in dB, indicating the difference of the sound
signal level at which 50% of the words were repeated correctly
with a constant noise level of 65 dB SPL. The SNRs for stimuli
delivered via each of the three different setupsweremeasured once
with the implant turned on as the aided condition and oncewith the
implant turned off as the unaided condition. Thus, ‘‘benefit’’ was
defined as a nominal decrease of the SNR, expressed as a negative
value, calculated as the difference of the SNR between the aided
and unaided condition. Patients used the universal setting of the
device, where the microphone is set in omnidirectional mode.
They were asked to keep their head stable and to remain looking
at the speaker in the frontal position. All nine patients were tested
approximately 12 months after implantation (mean, 13 T 2.5 months;
range, 10.5Y19.5 months). Six of the nine patients were also tested
at the fitting appointment approximately 30 days after implanta-
tion (mean, 28.5 T 7.7 days, range 20 to 39 days) and at an in-
termediate interval of at least 6 months after implantation (mean,
7 T 0.5 months; range, 6.5Y8 months).
Questionnaires
Two questionnaires were administered for each patient: 1) A
modified version of the Speech, Spatial and Qualities of Hearing
questionnaire (SSQ) (26), the SSQ-B (27); 2) the Bern Benefit in
Single-Sided Deafness Questionnaire (BBSS) questionnaire (28).
Both questionnaires specifically ask participants to compare their
hearing abilities in the aided condition versus the unaided condi-
tion on an ordinal scale ranging from j5 (much worse) to +5
(much better). The SSQ-B is divided into three categories and
consists of 49 questions; the BBSS consists of 10 questions.
RESULTS
Demographics
A total of nine patients (four female, five male) with SSD
matched the inclusion criteria. Table 1 provides de-
mographic, etiologic, and preoperative speech discrimina-
tion score data. The mean (TSD) age at implantation was 52
(T15) years. The implantation was performed on the left side
in three, and on the right side in six patients. The most
common cause for SSDwas acute sensorineural hearing loss
(SNHL) (three of nine), followed by labyrinthitis (two of
nine). One patient was previously implanted with a pBCD
system 6.5 years earlier. The decision to change to a tBCD
was made due to recurring local infections and skin over-
growth. For eight patients, the tBCD implantation was the
first surgical intervention for SSD.
The mean follow-up period was 16 months (range,
11Y22 months). Placement of the implant into the mas-
toid was possible in all patients without the need for
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retrosigmoidal placement. In one patient, the tBCD was
in contact with the dura of the middle cranial fossa and
the sigmoid sinus; however, there was no relevant im-
pression made on these structures. In one patient, pro-
longed swelling in the wound region occurred, which
resolved without further intervention. In a second patient,
oral antibiotic therapy was necessary because of a post-
operative wound infection, which resolved completely
after 1 week of treatment. No patient had to undergo re-
vision surgery.
Audiometry
Preoperatively, seven patients had no measurable BC
thresholds on the affected ear side. Two patients had mea-
surable BC thresholds resulting in BC PTAs on the affected
side of 51 dB HL and 64 dB HL, respectively; however,
these patients had speech discrimination scores of 40% and
0% at 100 dB SPL, respectively. The better ear had an AC
PTAof 20 dBHLor better in 7 patients, and in 2 patients, the
AC PTA was between 20 and 30 dB HL (Fig. 1). The pre-
and postoperative AC and BC PTAs did not change sig-
nificantly for either ear.
The OLSA results for all patients (n = 9) in aided and
unaided conditions 12 months after the operation are
summarized in Figure 2a. The corresponding test setups
are shown below in Figure 2b. For test situation 1 (S0N0),
the mean SNR in the unaided condition was j2.82 dB
and j2.14 dB in the aided condition. In situation 2
(SCLN0), the mean SNR increased from j7.27 to j6.52
dB. In situation 3 (SBBN0), the SNR decreased from -1.73
to j3.38 dB. The change was statistically significant
only for situation 3 (p G 0.05, repeated ANOVA with
Bonferroni correction).
The OLSA was measured at three time points postop-
eratively (1, 6, and 12 months) in 6 patients (3 of the 9
patients were measured only at 12 months, postoperative-
ly). The difference of the SNR between the aided and
unaided conditions at the different time points is shown in
Figure 3 and represents functional benefit. One month after
the operation, the benefit was small (SNR difference of
j0.9 dB) and not statistically significant. After 6 months,
the benefit increased and became significant (p G 0.05,
repeated ANOVA with Bonferroni correction) when the
SNR difference changed toj2.1 dB. After 12 months, the
benefit in the OLSA increased slightly again as the SNR
reachedj2.2 dB and remained statistically significant (p G
0.05) compared with the unaided condition.
Questionnaire
Six patients completed the questionnaires at 6 months
after tBCD implantation. The questionnaires of 3 patients
were received later (12, 14, and 20 months after im-
plantation). As shown in Figure 3, the benefit at 6 and 12
months is comparable. Therefore, the questionnaires were
analyzed together.
Figure 4 illustrates the mean values for the 10 questions
of the BBSS. The mean results for each question were
positive, meaning that on average, the patients had good
benefit from the device. However, the amount of benefit
among subjects varied by up to 4.5 points. One patient
reported no benefit and answered all questions as nega-
tive or 0, while all other patients responded only with
positive values. The patient with the lowest score for the
BBSS also showed the lowest score on the OLSA. A
statistically significant association (Spearman rank cor-
relation coefficient R = 0.72, p = 0.03) exists between
subjective benefits (mean BBSS score) and objective
TABLE 1. Demographic and clinical data
Patient
Age at
Surgery Sex Pathology
Side of
SSD
Maximal Speech
Discrimination Score
of Implanted Ear
1 57 yr M Acute SNHL Left 0%
2 57 yr F Acute SNHL Right 0%
3 49 yr F M. Meniere Right 40%
4 46 yr M Labyrinthitis Right 0%
5 18 yr F Progressive SNHL Left 0%
6 42 yr M Acute SNHL Right 0%
7 62 yr F Temporal bone
fracture
Right 10%
8 65 yr M Viral infection
in childhood
Left 5%
9 69 yr M Labyrinthitis Right 0%
M, male; F, female.
FIG. 1. Audiometric data. Air conduction and BC hearing thresholds of the better ear and the ear implanted with a tBCD (dB HL), shown as
mean (graph) with range.
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speech in noise score (mean of absolute SNR in all three
aided conditions). As expected, localization of sound is
the most difficult task for SSD subjects resulting in the
lowest score for question 9 of the BBSS (‘‘To localize a
sound source, such as a honking car. For me, this is:I’’)
with a mean score of 0.44.
Figure 5 illustrates the results from the SSQ-B. The
mean score for all questions combined was positive. The
speech section of the SSQ-B (Fig. 5a) yielded the most
positive scores while results were somewhat closer to
0 for the spatial (Fig. 5b) and qualities sections (Fig. 5c).
For the BBSS, most of the negative values from all sec-
tions originated from one patient, who correspondingly
showed the lowest improvement on the OLSA in the
aided condition. This patient is listed as Nr. 6 in Table 1.
After 10 years of SSD due to acute sensorineural hearing
loss, he sought auditory rehabilitation because of a new
job in the noisy environment of a bar/restaurant. At the
time of surgery, his better hearing ear showed a notched
hearing loss with thresholds of 30 dB HL at 3,000 Hz,
35 dB HL at 4,000 Hz, and 45 dB HL at 6,000 Hz. The
pre- and postoperative course was uneventful.
DISCUSSION
The primary goal of this study was to evaluate the
clinical benefit of a tBCD for patients with SSD. We
chose two different approaches to evaluate the patients’
benefit, the OLSA tomeasure objective audiometric benefit
and two questionnaires to evaluate subjective benefit.
The three different test setups for the OLSA represent
three situations that are encountered in everyday life
(Fig. 2b). Situation 1 simulates a conversation in noise.
Situation 2 is designed to measure the negative effect a
CROS system might cause by adding an additional noise
signal, and situation 3 simulates the head shadow effect, a
situation in which maximal improvement in speech rec-
ognition in the aided condition is expected. The mea-
surements showed a small, but not significant, decrease
of SNR between the aided and unaided conditions in
situations 1 and 2 at 12 months after the surgery (Fig. 2a).
Speech recognition scores showed that an amplified noise
signal does not affect the speech signal in situations with
noise coming from the frontal direction and the speech
signal either from the unaffected side or from the front
(Fig. 2b, situations 1 and 2). A significant improvement
FIG. 2. Speech understanding in noise and test setups. a) SNR in
the OLSA for the aided and unaided condition. In the upper part,
results are shown as box-and-whisker diagrams with mean (+) and
range. n.s., nonsignificant (p 9 0.05), n = 9. b) on the left: test situ-
ation 1 (S0N0); in the middle: test situation 2 (SCLN0); on the right:
test situation 3 (SBBN0). S, position of sound signal source (speech);
N, position of noise source.
FIG. 3. Speech understanding benefit improvement over time.
Difference of SNR in the OLSA for aided and unaided condition
in test setup 3 is shown as bar (mean) with SEM. First fit was done
1 month postoperatively. Statistical analysis was done in com-
parison to 0 (no benefit).
FIG. 4. BBSS results. y axis indicates the order of the questions;
x axis, the scale that was used for the participant’s response.
Results are shown as boxplots with mean (+), median (horizontal
line) and whiskers (range).
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of j1.65 dB SNR was found for situation 3. This im-
provement is lower compared with findings with a BAHA
system that reported improvements of j2.1 to j3.9 dB
(29Y31) (8). One reason for this difference may be the
setting of the microphone (omnidirectional) compared
with a directional microphone mode. However, it was
shown in another study (32) that the setting of the mi-
crophone (omnidirectional vs directional) has no signifi-
cant effect on speech understanding when measured in a
setup such as in situation 3 (S90N0) in our study. One of
our patients did not benefit from the device in any cate-
gories. Because of the small number of patients included,
the effect of a nonresponder has a large impact on the
overall results. However, this type of study is limited
by the small number of patients meeting the inclusion
criteria. It is difficult to judge the superiority of one
system over another (i.e., tBCD vs pBCD), because no
direct comparison of different devices in a randomized
clinical trial is possible because of ethical considerations.
An experimental comparison in cadaver heads of the BB
and the BAHA did not show a significant difference be-
tween the devices with respect to vibration of the skull
measured on the promontory (17). One of the patients
included was previously implanted with a pBCD. Al-
though he described inferior hearing quality with the
tBCD in comparison with his previous device, he was
very satisfied with the tBCD because of the lack of re-
current local infections.
An interesting finding was the improvement in situa-
tion 3 after an extended follow-up period (Fig. 3), indi-
cated by a decrease in SNR. After 1 month, improvement
was not significantly different from zero. Only after
6 months a significant decrease of SNR was observed,
and after 12 months, SNR decreased further. This finding
stresses the importance of experience for patients with
SSD provided with a tBCD and helps in counseling them
preoperatively. It remains unclear whether a longer follow-
up period would produce further change in SNR.
Our results only showed significant benefit in speech
understanding for situation 3, whereas no improvement in
SNRwas found for situations 1 and 2. The question remains
open as to whether the audiologic improvement in situation
3 results in better quality of life with regard to hearing.
Therefore, patient satisfaction plays a crucial role in eval-
uating a new device for SSD treatment. The outcomes of the
BBSS and the SSQ-B questionnaires used in this study
were generally positive (89%).Only one patient (11%)was
dissatisfied, which corresponds to the findings of others (33).
The association between duration of deafness and
growth of benefit expressed as the difference between
benefit after first fit and after 12 months (Fig. 3) was sta-
tistically significant (Spearman rank correlation coefficient
R = j0.77, p G 0.01). Overall, patients with longer lasting
SSD needed more time to reach satisfactory speech rec-
ognition results than did those with a shorter duration.
It remains unclear whether follow-up over a longer period
of time would further increase SNR benefit differently
depending on the duration of deafness prior to first fit.
The primary advantage of a tBCD as compared with a
pBCD is the integrity of the skin. The risk of a recurrent
infection is much smaller, and the microphone is clearly
separated from the sound generator, resulting in less
acoustic feedback (17). When the outer processor is not
worn, the flatness of the implant and the intact skin
conditions might look more natural, adding to a possible
positive psychological aspect. In addition, the device
might pose less of an obstacle in comparison with a metal
screw when wearing head protection such as helmets. The
FIG. 5. SSQ-B results. Part 1, Speech; Part 2, Spatial; Part 3, Qualities. y axis indicates the order of the questions, x axis the scale that was
used for the participant’s response. Results are shown as boxplots with mean (+), median (horizontal line), and whiskers (range).
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BBSS and SSQ-B did not have specific questions con-
cerning these differences, and we cannot draw any final
conclusion about these factors affecting quality of life.
The patients did not experience any postoperative
complications that affected the outcome of the operation.
Most patients had both subjective and objective benefit
from the device.
CONCLUSION
Speech discrimination in noise for patients with a BB
is comparable to patients with other BC hearing aids.
A learning curve of up to 6 months was observed. The
subjective benefit was rated positively by the patients.
With the advantage of intact skin conditions after im-
plantation, we consider the BB to be an adequate option
for patients with SSD.
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